Concepedia

Joseph E. Spahr

JE

Statistics

Publications

3

Citations

2.8K

H-Index

3

Active since

2006

Affiliations

Hematology Oncology Consultants(Current)

University of California, Los Angeles

Dnipro State Medical University

Semmelweis University

Okayama University Hospital

Joseph E. Spahr is an author at Hematology Oncology Consultants specializing in medicine, cancer therapeutics, and lung cancer.

Top concepts

Publications per year

2006–2020

3

Publications

3

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Luis Paz‐Ares, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet · 2019 · 2.1K citations

, , +6

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

Jonathan W. Goldman, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet Oncology · 2020 · 662 citations · Full text

, , +6

Acquired amegakaryocytic thrombocytopenic purpura

Neeraj Agarwal, Joseph E. Spahr, Theresa L. Werner et al. · American Journal of Hematology · 2006 · 40 citations

, , +15

1–3 of 3